Published in Nat Rev Microbiol on February 07, 2011
Evolutionary dynamics of Staphylococcus aureus during progression from carriage to disease. Proc Natl Acad Sci U S A (2012) 3.29
Novel antibody-antibiotic conjugate eliminates intracellular S. aureus. Nature (2015) 2.04
The stringent response of Staphylococcus aureus and its impact on survival after phagocytosis through the induction of intracellular PSMs expression. PLoS Pathog (2012) 1.46
Inactivation of staphylococcal phenol soluble modulins by serum lipoprotein particles. PLoS Pathog (2012) 1.45
Phenol-soluble modulins--critical determinants of staphylococcal virulence. FEMS Microbiol Rev (2014) 1.21
Staphylococcal alpha-phenol soluble modulins contribute to neutrophil lysis after phagocytosis. Cell Microbiol (2013) 1.19
A bacterial siren song: intimate interactions between Neisseria and neutrophils. Nat Rev Microbiol (2012) 1.14
Staphylococcus aureus protein A mediates invasion across airway epithelial cells through activation of RhoA GTPase signaling and proteolytic activity. J Biol Chem (2011) 1.11
A privileged intraphagocyte niche is responsible for disseminated infection of Staphylococcus aureus in a zebrafish model. Cell Microbiol (2012) 1.03
A NET Outcome. Front Immunol (2012) 1.00
The dormant blood microbiome in chronic, inflammatory diseases. FEMS Microbiol Rev (2015) 0.99
The CovS/CovR acid response regulator is required for intracellular survival of group B Streptococcus in macrophages. Infect Immun (2012) 0.98
The impact of α-toxin on host cell plasma membrane permeability and cytokine expression during human blood infection by CA-MRSA USA300. J Leukoc Biol (2013) 0.88
Differential responses of osteoblasts and macrophages upon Staphylococcus aureus infection. BMC Microbiol (2014) 0.86
Neutrophil crawling in capillaries; a novel immune response to Staphylococcus aureus. PLoS Pathog (2014) 0.85
The β-hemolysin and intracellular survival of Streptococcus agalactiae in human macrophages. PLoS One (2013) 0.84
Clonal expansion during Staphylococcus aureus infection dynamics reveals the effect of antibiotic intervention. PLoS Pathog (2014) 0.84
How Neutrophils Shape Adaptive Immune Responses. Front Immunol (2015) 0.84
Filifactor alocis infection and inflammatory responses in the mouse subcutaneous chamber model. Infect Immun (2013) 0.83
Improved outcome with early rifampicin combination treatment in methicillin-sensitive Staphylococcus aureus bacteraemia with a deep infection focus - a retrospective cohort study. PLoS One (2015) 0.83
Memory Th1 Cells Are Protective in Invasive Staphylococcus aureus Infection. PLoS Pathog (2015) 0.82
Clearance of apoptotic neutrophils and resolution of inflammation. Immunol Rev (2016) 0.82
Natural mutations in a Staphylococcus aureus virulence regulator attenuate cytotoxicity but permit bacteremia and abscess formation. Proc Natl Acad Sci U S A (2016) 0.81
Feedback-based, system-level properties of vertebrate-microbial interactions. PLoS One (2013) 0.80
Differing mechanisms of surviving phagosomal stress among group B Streptococcus strains of varying genotypes. Virulence (2016) 0.80
Manipulation of Autophagy in Phagocytes Facilitates Staphylococcus aureus Bloodstream Infection. Infect Immun (2015) 0.79
Individuality, phenotypic differentiation, dormancy and 'persistence' in culturable bacterial systems: commonalities shared by environmental, laboratory, and clinical microbiology. F1000Res (2015) 0.79
Staphylococcus aureus Strain USA300 Perturbs Acquisition of Lysosomal Enzymes and Requires Phagosomal Acidification for Survival inside Macrophages. Infect Immun (2015) 0.78
Staphylococcus aureus sortase A contributes to the Trojan horse mechanism of immune defense evasion with its intrinsic resistance to Cys184 oxidation. Biochemistry (2011) 0.78
Macrophage Bactericidal Activities against Staphylococcus aureus Are Enhanced In Vivo by Selenium Supplementation in a Dose-Dependent Manner. PLoS One (2015) 0.77
Staphylococcus aureus in continuous culture: a tool for the rational design of antibiotic treatment protocols. PLoS One (2012) 0.77
Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia (ARREST): study protocol for a randomised controlled trial. Trials (2012) 0.77
AcuC, a histone deacetylase, contributes to the pathogenicity of Aeromonas hydrophila. Microbiologyopen (2017) 0.77
The role of the microbiota in surgical recovery. Curr Opin Clin Nutr Metab Care (2016) 0.76
Pharmacokinetics and pharmacodynamics of DSTA4637A: A novel THIOMAB™ antibody antibiotic conjugate against Staphylococcus aureus in mice. MAbs (2016) 0.76
Biofilm-Forming Methicillin-Resistant Staphylococcus aureus Survive in Kupffer Cells and Exhibit High Virulence in Mice. Toxins (Basel) (2016) 0.76
A Dormant Microbial Component in the Development of Preeclampsia. Front Med (Lausanne) (2016) 0.76
MRI Based Localisation and Quantification of Abscesses following Experimental S. aureus Intravenous Challenge: Application to Vaccine Evaluation. PLoS One (2016) 0.75
The T Cell Response to Staphylococcus aureus. Pathogens (2016) 0.75
Major involvement of bacterial components in rheumatoid arthritis and its accompanying oxidative stress, systemic inflammation and hypercoagulability. Exp Biol Med (Maywood) (2016) 0.75
Serine-aspartate-repeat protein D Increases Staphylococcus aureus Virulence and Survival in Blood. Infect Immun (2016) 0.75
Intestinal Bacteria Composition and Translocation of Bacteria in Inflammatory Bowel Disease. PLoS One (2017) 0.75
Immune evasion by a staphylococcal inhibitor of myeloperoxidase. Proc Natl Acad Sci U S A (2017) 0.75
Importance of strain lineages for Group B streptococcal survival. Virulence (2016) 0.75
Intrinsic Maturational Neonatal Immune Deficiencies and Susceptibility to Group B Streptococcus Infection. Clin Microbiol Rev (2017) 0.75
Staphylococcus aureus infections. N Engl J Med (1998) 36.39
THE PROTECTION OF PATHOGENIC MICROORGANISMS BY LIVING TISSUE CELLS. J Exp Med (1916) 18.60
The survival of staphylococci within human leukocytes. J Exp Med (1952) 12.41
Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis (2009) 11.12
Community-associated meticillin-resistant Staphylococcus aureus. Lancet (2010) 9.07
Immune evasion by staphylococci. Nat Rev Microbiol (2005) 7.22
Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004. J Infect Dis (2008) 5.41
Insights into mechanisms used by Staphylococcus aureus to avoid destruction by human neutrophils. J Immunol (2005) 5.18
The role of the granuloma in expansion and dissemination of early tuberculous infection. Cell (2009) 4.79
The protection of intracellular brucella against streptomycin alone and in combination with other antibiotics. J Lab Clin Med (1951) 4.77
Accurate and rapid identification of bacterial species from positive blood cultures with a DNA-based microarray platform: an observational study. Lancet (2009) 4.53
Killing of intraleukocytic Staphylococcus aureus by rifampin: in-vitro and in-vivo studies. J Infect Dis (1972) 4.40
Interaction of intraleukocytic bacteria and antibiotics. J Clin Invest (1973) 3.96
Evolving concepts in biofilm infections. Cell Microbiol (2009) 3.90
Regulation of virulence determinants in vitro and in vivo in Staphylococcus aureus. FEMS Immunol Med Microbiol (2004) 3.88
Staphylococcus aureus capsular polysaccharides. Clin Microbiol Rev (2004) 3.40
Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity. J Exp Med (2005) 3.36
Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch Intern Med (2003) 3.31
Studies on bacteriemia. I. Mechanisms relating to the persistence of bacteriemia in rabbits following the intravenous injection of staphylococci. J Exp Med (1956) 3.21
Protection of phagocytized bacteria from the killing action of antibiotics. Nature (1966) 3.12
Survival of Staphylococcus aureus inside neutrophils contributes to infection. J Immunol (2000) 3.08
Intracellular survival of staphylococci. J Exp Med (1959) 3.00
Further observations on the behavior of staphylococci within human leukocytes. J Exp Med (1960) 2.89
Persistent bacteremia due to methicillin-resistant Staphylococcus aureus infection is associated with agr dysfunction and low-level in vitro resistance to thrombin-induced platelet microbicidal protein. J Infect Dis (2004) 2.83
Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK. J Antimicrob Chemother (2006) 2.82
Intracellular Staphylococcus aureus escapes the endosome and induces apoptosis in epithelial cells. Infect Immun (1998) 2.63
Bacterial pathogens modulate an apoptosis differentiation program in human neutrophils. Proc Natl Acad Sci U S A (2003) 2.54
A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance. Medicine (Baltimore) (2003) 2.51
Healthcare-associated bloodstream infection: A distinct entity? Insights from a large U.S. database. Crit Care Med (2006) 2.51
Staphylococcus aureus as an intracellular pathogen: the role of small colony variants. Trends Microbiol (2009) 2.38
Mortality after Staphylococcus aureus bacteraemia in two hospitals in Oxfordshire, 1997-2003: cohort study. BMJ (2006) 2.37
Is Staphylococcus aureus an intracellular pathogen? Trends Microbiol (2000) 2.31
Treatment and outcome of Staphylococcus aureus bacteremia: a prospective study of 278 cases. Arch Intern Med (2002) 2.24
Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA). Int J Antimicrob Agents (2007) 2.23
Staphylococcal innate immune evasion. Trends Microbiol (2005) 2.18
Staphylococcus aureus bacteraemia: a major cause of mortality in Australia and New Zealand. Med J Aust (2009) 2.16
A potential new pathway for Staphylococcus aureus dissemination: the silent survival of S. aureus phagocytosed by human monocyte-derived macrophages. PLoS One (2008) 2.12
Host defense and pathogenesis in Staphylococcus aureus infections. Infect Dis Clin North Am (2009) 2.01
The significance of nasal carriage of Staphylococcus aureus and the incidence of postoperative wound infection. J Hosp Infect (1995) 1.94
Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule? Nat Rev Drug Discov (2008) 1.93
Staphylococcus aureus: new evidence for intracellular persistence. Trends Microbiol (2009) 1.92
Pharmacodynamic evaluation of the intracellular activities of antibiotics against Staphylococcus aureus in a model of THP-1 macrophages. Antimicrob Agents Chemother (2006) 1.89
Mechanism and consequences of invasion of endothelial cells by Staphylococcus aureus. Thromb Haemost (2005) 1.87
Staphylococcus aureus Agr and Sar global regulators influence internalization and induction of apoptosis. Infect Immun (1998) 1.86
Salvage treatment for persistent methicillin-resistant Staphylococcus aureus bacteremia: efficacy of linezolid with or without carbapenem. Clin Infect Dis (2009) 1.85
Guidelines for the antibiotic treatment of endocarditis in adults: report of the Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother (2004) 1.85
The SaeR/S gene regulatory system is essential for innate immune evasion by Staphylococcus aureus. J Infect Dis (2009) 1.74
The SarA protein family of Staphylococcus aureus. Int J Biochem Cell Biol (2007) 1.69
Intraleukocytic sequestration as a cause of persistent Staphylococcus aureus peritonitis in continuous ambulatory peritoneal dialysis. Am J Med (1984) 1.64
Persistence in Staphylococcus aureus bacteremia: incidence, characteristics of patients and outcome. Scand J Infect Dis (2006) 1.63
Invasive non-typhoid salmonellae establish systemic intracellular infection in HIV-infected adults: an emerging disease pathogenesis. Clin Infect Dis (2010) 1.63
Staphylococcus aureus bacteremia in patients with hematologic malignancies: a retrospective case-control study. Haematologica (2003) 1.57
Fate of staphylococci within human leukocytes. J Exp Med (1960) 1.55
Molecular mechanisms of complement evasion: learning from staphylococci and meningococci. Nat Rev Microbiol (2010) 1.52
CD4+ T cells and CXC chemokines modulate the pathogenesis of Staphylococcus aureus wound infections. Proc Natl Acad Sci U S A (2006) 1.49
Intracellular pharmacodynamics of antibiotics. Infect Dis Clin North Am (2003) 1.47
Phagocytosis of Staphylococcus aureus by macrophages exerts cytoprotective effects manifested by the upregulation of antiapoptotic factors. PLoS One (2009) 1.41
Evidence of an intracellular reservoir in the nasal mucosa of patients with recurrent Staphylococcus aureus rhinosinusitis. J Infect Dis (2005) 1.39
In vitro resistance to thrombin-induced platelet microbicidal protein is associated with enhanced progression and hematogenous dissemination in experimental Staphylococcus aureus infective endocarditis. Infect Immun (1998) 1.37
Phenotypic and genotypic characteristics of persistent methicillin-resistant Staphylococcus aureus bacteremia in vitro and in an experimental endocarditis model. J Infect Dis (2009) 1.37
Staphylococcus aureus agr and sarA functions are required for invasive infection but not inflammatory responses in the lung. Infect Immun (2002) 1.36
Dissemination of Listeria monocytogenes by infected phagocytes. Infect Immun (1999) 1.34
Staphylococcus aureus host cell invasion and post-invasion events. Int J Med Microbiol (2009) 1.28
Autoradiographic evidence for the impermeability of mouse peritoneal macrophages to tritiated streptomycin. J Bacteriol (1967) 1.27
Management of methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis (2008) 1.26
Staphylococcus aureus bacteremia in patients with prosthetic devices: costs and outcomes. Am J Med (2005) 1.23
Biphasic intracellular expression of Staphylococcus aureus virulence factors and evidence for Agr-mediated diffusion sensing. Mol Microbiol (2003) 1.22
Staphylococcus aureus invades the epithelium in nasal polyposis and induces IL-6 in nasal epithelial cells in vitro. Allergy (2010) 1.21
Use of intravenous rifampin in neonates with persistent staphylococcal bacteremia. Antimicrob Agents Chemother (1993) 1.20
Colonization and infection of the human host by staphylococci: adhesion, survival and immune evasion. Vet Dermatol (2009) 1.20
Cellular pharmacodynamics and pharmacokinetics of antibiotics: current views and perspectives. Curr Opin Drug Discov Devel (2006) 1.20
Studies on bacteriemia. V. The effect of simultaneous leukopenia and reticuloendothelial blockade on the early blood stream clearance of staphylococci and Escherichia coli. J Exp Med (1961) 1.20
Factors influencing the internalization of Staphylococcus aureus and impacts on the course of infections in humans. Appl Microbiol Biotechnol (2001) 1.18
Persistent Staphylococcus aureus bacteremia: incidence and outcome trends over time. Scand J Infect Dis (2009) 1.15
Real-time monitoring of intracellular Staphylococcus aureus replication. J Bacteriol (2004) 1.11
Intracellular persisting Staphylococcus aureus is the major pathogen in recurrent tonsillitis. PLoS One (2010) 1.07
Use of aminoglycosides in treatment of infections due to intracellular bacteria. Antimicrob Agents Chemother (2001) 1.07
Combined effect of pH and concentration on the activities of gentamicin and oxacillin against Staphylococcus aureus in pharmacodynamic models of extracellular and intracellular infections. J Antimicrob Chemother (2007) 1.05
Staphylococcal catalase protects intracellularly survived bacteria by destroying H2O2 produced by the murine peritoneal macrophages. Microb Pathog (2009) 1.04
Sequestration of staphylococci at an inaccessible focus. Lancet (1979) 1.03
Effect of low intraphagolysosomal pH on antimicrobial activity of antibiotics against ingested staphylococci. J Med Microbiol (1983) 1.02
Clinical relevance of increasing glycopeptide MICs against Staphylococcus aureus. Int J Antimicrob Agents (2008) 1.02
The location of Staphylococcus aureus in experimental chronic mastitis in the mouse and the effect on the action of sodium cloxacillin. Br J Exp Pathol (1979) 1.01
Comparative study of clinical characteristics of neutropenic and non-neutropenic adult cancer patients with bloodstream infections. Eur J Clin Microbiol Infect Dis (2006) 1.00
Activity of antibiotics against Staphylococcus aureus within polymorphonuclear neutrophils. Eur J Clin Microbiol Infect Dis (1991) 0.99
The rise and rise of Staphylococcus aureus: laughing in the face of granulocytes. Clin Exp Immunol (2009) 0.98
Activities of ceftobiprole and other cephalosporins against extracellular and intracellular (THP-1 macrophages and keratinocytes) forms of methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2009) 0.96
Continuous versus intermittent infusion of oxacillin for treatment of infective endocarditis caused by methicillin-susceptible Staphylococcus aureus. Antimicrob Agents Chemother (2009) 0.93
Autoregulation mechanism of human neutrophil apoptosis during bacterial infection. Mol Immunol (2007) 0.91
Phagolysosomal integrity is generally maintained after Staphylococcus aureus invasion of nonprofessional phagocytes but is modulated by strain 6850. Infect Immun (2010) 0.88
Role of rsbU and staphyloxanthin in phagocytosis and intracellular growth of Staphylococcus aureus in human macrophages and endothelial cells. J Infect Dis (2009) 0.88
Successful treatment of daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus bacteremia with the addition of rifampin to daptomycin. Ann Pharmacother (2010) 0.86
Intraphagocytic protection of staphylococci from extracellular penicillin. J Med Microbiol (1982) 0.84
Clinical outcomes and costs among patients with Staphylococcus aureus bacteremia and orthopedic device infections. Scand J Infect Dis (2008) 0.83
Intra- and extracellular activities of dicloxacillin against Staphylococcus aureus in vivo and in vitro. Antimicrob Agents Chemother (2010) 0.82
Uptake and intracellular activity of linezolid in human phagocytes and nonphagocytic cells. Antimicrob Agents Chemother (2002) 0.81
Antibiotic activity against intraleukocytic Staphylococcus aureus in vitro and in experimental mastitis in mice. Am J Vet Res (1983) 0.80
Uptake, transport, delivery, and intracellular activity of antimicrobial agents. Pharmacotherapy (2005) 0.80
Initial low-dose aminoglycosides in Staphylococcus aureus bacteremia: good science, urban legend, or just plain toxic? Clin Infect Dis (2009) 0.77
Comparison of fluorescence in situ hybridisation using peptide nucleic acid probes, Gram stain/acridine orange leukocyte cytospin and differential time to positivity methods for detection of catheter-related bloodstream infection in patients after haematopoietic stem cell transplantation. Clin Microbiol Infect (2010) 0.76
Accurate and rapid identification of bacterial species from positive blood cultures with a DNA-based microarray platform: an observational study. Lancet (2009) 4.53
A genomic portrait of the emergence, evolution, and global spread of a methicillin-resistant Staphylococcus aureus pandemic. Genome Res (2013) 2.59
The impact of enhanced cleaning within the intensive care unit on contamination of the near-patient environment with hospital pathogens: a randomized crossover study in critical care units in two hospitals. Crit Care Med (2011) 2.23
Interactions of lactoferricin-derived peptides with LPS and antimicrobial activity. FEMS Microbiol Lett (2004) 1.01
A cost-effectiveness analysis of caspofungin vs. liposomal amphotericin B for treatment of suspected fungal infections in the UK. Eur J Haematol (2007) 0.99
Respiratory tract infections in the immunocompromised. Curr Opin Pulm Med (2013) 0.92
Healthcare environments and spatial variability of healthcare associated infection risk: cross-sectional surveys. PLoS One (2013) 0.81
Accurate and rapid identification of Candida spp. frequently associated with fungemia by using PCR and the microarray-based Prove-it Sepsis assay. J Clin Microbiol (2012) 0.79
Community-acquired pneumonia. Curr Opin Pulm Med (2003) 0.78
Hospital door handle design and their contamination with bacteria: a real life observational study. Are we pulling against closed doors? PLoS One (2012) 0.78
Aetiology of hospital-acquired pneumonia and trends in antimicrobial resistance. Curr Opin Pulm Med (2014) 0.78
An improved fluorescent amplified fragment length polymorphism method for typing Mycobacterium tuberculosis. J Clin Microbiol (2006) 0.75